Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review BREAKING NEWS: Peptides are coming In July, the FDA is reviewing BPC 157, TB 500, Semax, Epitalon and more. The meeting will be open to the public. The peptide era begins. FDA Puts BPC 157, TB 500, and 5 Other Peptides Under the Microscope: What Prescribers Need to Know About the 503A Review Lengea BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with